Minimally-invasive cytoreduction in recurrent endometrial cancer: laparoscopic and uniportal video-assisted thoracoscopic surgery (VATS) combined approach

ESGO eAcademy, Nicolo Bizzari, 287843

Principles of Writing a Good Scientific Manuscript

ESGO eAcademy, Pedro Ramirez, 286732

Breaking bad news: What, as doctors, can we do better?

ESGO eAcademy, Jalid Sehouli, 282885

The patient's perspective

ESGO eAcademy, Charo Hierro, 282879

The medical oncologist's perspective

ESGO eAcademy, Jonathan Ledermann, 282878

What do patients need to improve their QoL?

ESGO eAcademy, Esra Urkmez, 282884

The gynaeco-oncologist's perspective

ESGO eAcademy, Denis Querleu, 282877

The clinical geneticist's perspective

ESGO eAcademy, Emmanouil Saloustros, 282876

The clinical scientist's perspective

ESGO eAcademy, Charlie Gourley, 282875

The pathologist's perspective

ESGO eAcademy, Matias-Guiu Guia, 282874

How to assess PROs and quality of life?

ESGO eAcademy, Florence Joly, 282882

Medical treatment and update on recent molecular studies

ESGO eAcademy, Alexandra Leary, 282871

New insights into surgical management of mucinous ovarian cancer

ESGO eAcademy, Philippe Morice, 282870

PRO

ESGO eAcademy, Ingfrid Haldorsen, 282866

Restrictions in the histopathological diagnosis of mucinous ovarian carcinoma

ESGO eAcademy, Kitty Pavlakis, 282869

Medicamentous risk-reducing strategies after sporadic gynaecological malignancies

ESGO eAcademy, Cristiana Sessa, 282859

Chemotherapy and molecular prognostic significance in locally advanced vulvar cancer

ESGO eAcademy, Muieddine Seoud, 282864

Medicamentous risk-reducing management in BRCA mutation carriers

ESGO eAcademy, Shani Paluch-Shimon, 282858

Radiation therapy in the treatment of locally advanced vulvar cancer

ESGO eAcademy, Anuja Jhingran, 282863

Surgical risk-reducing strategies in BRCA mutation carriers

ESGO eAcademy, Pauline Wimberger, 282857

Surgery in the treatment of locally advanced vulvar cancer

ESGO eAcademy, Fuat Demirkiran, 282862

Lesser sack, porta hepatis, and celiac trunk

ESGO eAcademy, Cagatay Taskiran, 282854

The microbiome, carcinogenesis, and prognosis: Driver or passenger?

ESGO eAcademy, Julien Marchesi, 282848

Splenectomy, distal pancreatectomy, and partial gastrectomy

ESGO eAcademy, Pawel Knapp, 282853

The vaginal microbiome, HPV infection, and progression of cervical disease

ESGO eAcademy, Murat Gultekin, 282847

Carcinogenesis and prognosis in gynaecological cancers: Is this microbiome-related?

ESGO eAcademy, Maria Kyrgiou, 282846

Assessment of resectability: Imaging and/or laparoscopy

ESGO eAcademy, Anna Fagotti, 282851

Case presentation of foetal and neonatal follow-up during and after chemo during pregnancy

ESGO eAcademy, Monica Fumagalli, 282843

Adding translational research in Gyn Cancer trials

ESGO eAcademy, Sandro Pignata, 282838

Case presentation of cervical cancer during pregnancy

ESGO eAcademy, Frederic Amant, 282842

Innovation in endometrial cancer and cervical cancer

ESGO eAcademy, Antonio Gonzalez, 282837

Innovation in ovarian cancer

ESGO eAcademy, Isabelle Ray-Coquard, 282836

Case presentation of breast cancer during pregnancy

ESGO eAcademy, Michael Halaska, 282841

Advances in techniques for external beam radiotherapy and brachytherapy in cervical cancer

ESGO eAcademy, Jacob Lindegaard, 282833

The way forward: Novel agents in development

ESGO eAcademy, Ros Glasspool, 282828

Novel targets: A molecular perspective

ESGO eAcademy, Viola Heinzelmann, 282827

Parallel session 21: Platinum-resistant ovarian cancer: A new definition and novel approaches in a changing landscape

ESGO eAcademy, Antonio Gonzalez, 282825

Radiotherapy in cervical cancer, where do we come from? Where are we now? Where are we going?

ESGO eAcademy, Elzbieta van der Steen-Banasik, 282831

Sex cord stromal tumours in adolescents

ESGO eAcademy, Dominik Schneider, 282818

The role of immunotherapy in GTN

ESGO eAcademy, Ulrika Joneborg, 282823

Germ cell tumours in adolescents

ESGO eAcademy, Philippe Morice, 282817

How to manage placental site nodules, PSTT, and ETT

ESGO eAcademy, Michael Seckl, 282822

Specificities of treating cancers in adolescents

ESGO eAcademy, Gabriele Calaminus, 282816

The key ingredients for a successful GTD centre

ESGO eAcademy, Christianne Lok, 282821

Systemic molecular targeted therapies: Achievements and prospects

ESGO eAcademy, Jonathan Ledermann, 282807

Novel combinations in ovarian cancer

ESGO eAcademy, Johanna Mäenpää, 282813

MRI Guided Brachytherapy: Evolution and challenges

ESGO eAcademy, Johannes Dimopoulos, 282806

Novel targeted drugs in endometrial cancer

ESGO eAcademy, Mansoor R Mirza, 282812

Technological developments in surgery and the contribution of robotic surgery

ESGO eAcademy, Rainer Kimmig, 282805

Emerging targeted therapies in cervical cancer

ESGO eAcademy, Ana Oaknin, 282811

Vaccination: Achievements and challenges

ESGO eAcademy, Elmar Joura, 282804

DNA repair interfering therapies

ESGO eAcademy, Nicole Concin, 282810

Introduction Uzi Beller Award

ESGO eAcademy, Pedro Ramirez, 282799

Best translational research - Helga Salvesen Award

ESGO eAcademy, George Coukos, 282798

Introduction Helga Salvesen award

ESGO eAcademy, Cristiana Sessa, 282797

The role of immunotherapy in the management of gynecological cancers

ESGO eAcademy, Meletios A Dimopoulos, 282796

Is the new endometrial cancer classification ready for prime time?

ESGO eAcademy, Carien Creutzberg, 282794

Is there a role for immunotherapy in endometrial cancer?

ESGO eAcademy, Sandro Pignata, 282793

Is cytoreduction an option in advanced endometrial cancer

ESGO eAcademy, Elena Ulrikh, 282792

Chemotherapy in advanced endometrial cancer

ESGO eAcademy, Aristotelis Bamias, 282791

Radiotherapy in the elderly

ESGO eAcademy, Elzbieta van der Steen-Banasik, 282786

State of the Art 7: ESGO-GCIG Rare Tumours Guidelines

ESGO eAcademy, Isabelle Ray-Coquard, 282788

Medical treatment of elderly women with gynaecological cancers: Strategies for a heterogeneous population

ESGO eAcademy, Annamaria Ferrero, 282785

Pre-and postoperative evaluation, morbidity and postoperative outcome of elderly cancer patients

ESGO eAcademy, Dina Kurdiani, 282784

Genetic testing: The patient's perspective (patient rep from ENGAGE)

ESGO eAcademy, Birthe Lemley, 282781

Management of Lymph Nodes in Ovarian Cancer

ESGO eAcademy, Philipp Harter, 285950

Relevance of lymphadenectomy in cervical cancer in the SLN era

ESGO eAcademy, Fabrice Lecuru, 282775

Genetic counselling for Lynch syndrome in gynaecological cancers

ESGO eAcademy, Pawel Blecharz, 282780

Remaining indications for lymphadenectomy in ovarian cancer

ESGO eAcademy, Nicole Concin, 282774

BRCA mutations: Implications for the patient and family

ESGO eAcademy, Emmanouil Saloustros, 282779

Current role of pelvic and aortic lymphadenopathy in endometrial cancer

ESGO eAcademy, Nadeem Abu Rustum, 282773

Parallel session 13: Genetic testing and counselling in gynaecological cancers: Which patients, how, and by whom?

ESGO eAcademy, Susana Banerjee, 282777

A look at da Vinci robotic-assisted surgery postoperative results

ESGO eAcademy, Celine Lonnerfors, 282770

The place of da Vinci robotic-assisted surgery in an Enhanced Recovery program

ESGO eAcademy, Eric Lambaudie, 282769

Vulvar cancer

ESGO eAcademy, Ate van der Zee, 282767

ESGO meta-analysis for triage of HPV-positive cases

ESGO eAcademy, Marc Arbyn, 282760

Endometrial cancer

ESGO eAcademy, Nadeem Abu Rustum, 282766

Up-to-date in cervical cancer screening: ESGO-EFC joint statement

ESGO eAcademy, Jack Cuzick, 282759

Cervical cancer

ESGO eAcademy, David Cibula, 282765

State of the Art 5: ESGO-EFC new recommendations on prevention

ESGO eAcademy, Murat Gultekin, 282757

State of the art in HPV vaccination: ESGO-EFC joint statement

ESGO eAcademy, Elmar Joura, 282758

SLN ultrastaging

ESGO eAcademy, Glenn McCluggage, 282764

Perspectives in novel treatments

ESGO eAcademy, Domenica Lorusso, 282750

Enhanced Recovery Hospital Implementation Process (ERAS): A holistic approach

ESGO eAcademy, Pedro Ramirez, 282756

Is there a role for radiotherapy in high-risk early-stage disease?

ESGO eAcademy, Carien Creutzberg, 282749

Pre- and postoperative care: Focussing on nutrition and immunonutrition

ESGO eAcademy, Annamaria Ferrero, 282755

Is there a role for chemotherapy in high-risk early-stage disease?

ESGO eAcademy, Mansoor R Mirza, 282748

Perioperative anaesthetic management

ESGO eAcademy, Carolyn Weiniger, 282754

Endometrial cancer: A single disease?

ESGO eAcademy, Tjalling Bosse, 282747

The role of the Intensive Care Unit (ICU) in postoperative management

ESGO eAcademy, Nikolaos Thomakos, 282753

Presidential lecture

ESGO eAcademy, Denis Querleu, 282744

Surgical performance

ESGO eAcademy, Karl Tamussino, 282742

QI related to patients´ management

ESGO eAcademy, Francesco Raspagliesi, 282741

How to develop and how to use QI

ESGO eAcademy, David Cibula, 282740

Lessons learned: EWOC-1/EORTC55944/ PORTEC-3*

ESGO eAcademy, Nicoletta Colombo, 282737

First line ovarian cancer trials: VELIA/Forward1

ESGO eAcademy, Mansoor R Mirza, 282736

PARP combination studies: PRIMA/PAOLO-1/ANVANOVA2

ESGO eAcademy, Jonathan Ledermann, 282735

CON: open radical hysterectomy should be the new standard of care

ESGO eAcademy, Pedro Ramirez, 282728

PRO: Minimally invasive radical hysterectomy should remain the standard approach

ESGO eAcademy, Henrik Falconer, 282727

Discussion

ESGO eAcademy, Nadeem Abu Rustum, 286497